Christopher Kaufer

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Symptom-based clusters in people with post-COVID-19 condition (PCC).

Symptom-based clusters in people with post-COVID-19 condition (PCC).

Journal: Journal of translational medicine

Published: February 03, 2026

Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy.

Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy.

Journal: Current opinion in virology

Published: November 13, 2025

A holistic rat model to investigate therapeutic interventions in Parkinson's disease: viral induction of a slow-progressing motor phenotype, dopaminergic degeneration and early microglia neuroinflammation.

A holistic rat model to investigate therapeutic interventions in Parkinson's disease: viral induction of a slow-progressing motor phenotype, dopaminergic degeneration and early microglia neuroinflammation.

Journal: Brain research bulletin

Published: April 18, 2025

Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy.

Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy.

Journal: Journal of Parkinson's disease

Published: February 20, 2025

Intravenous SARS-CoV-2 Spike protein induces neuroinflammation and alpha-Synuclein accumulation in brain regions relevant to Parkinson's disease.

Intravenous SARS-CoV-2 Spike protein induces neuroinflammation and alpha-Synuclein accumulation in brain regions relevant to Parkinson's disease.

Journal: Brain, behavior, and immunity

Published: November 18, 2024

Infections in the Etiology of Parkinson's Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications.

Infections in the Etiology of Parkinson's Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications.

Journal: Journal of Parkinson's disease

Published: September 27, 2024

Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins.

Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins.

Journal: Neurobiology of disease

Published: September 04, 2024

The basolateral amygdala and striatum propagate alpha-synuclein pathology causing increased fear response in a Parkinson's disease model.

The basolateral amygdala and striatum propagate alpha-synuclein pathology causing increased fear response in a Parkinson's disease model.

Journal: Brain, behavior, and immunity

Published: September 04, 2024

Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model.

Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model.

Journal: EBioMedicine

Published: December 13, 2023

A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.

A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 16, 2022

Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-Synuclein.

Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-Synuclein.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 17, 2022

CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.

CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.

Journal: Cell reports. Medicine

Published: July 12, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026